Sign in Subscribe
Cancer research

COVID-19 Pandemic Disrupts Cervical Cancer Screening in Brazil

Strategic Insights

— 1 min read

The COVID-19 pandemic has significantly impacted cervical cancer screening in Brazil, highlighting vulnerabilities in the country's healthcare system. According to a new study published in the journal COVID, the pandemic led to a substantial reduction in Pap smear testing nationwide. This has severe consequences for women's health, particularly in low- and middle-income countries. The study emphasizes the need for strengthening organized screening programs to mitigate the long-term impact of these disruptions.

Key Takeaways:

  • The COVID-19 pandemic resulted in a significant reduction in Pap smear testing nationwide in Brazil, with a decrease of 30% in the number of tests performed during the pandemic period compared to the pre-pandemic period (p < 0.001).
  • The study found that the pandemic had a disproportionate impact on rural areas, where the reduction in Pap smear testing was more pronounced (40% decrease in rural areas compared to 25% in urban areas).
  • The researchers incorporated data from 2022-2023 to evaluate the volume of cytopathological exams performed in the post-pandemic context, showing a gradual increase in Pap smear testing but still below pre-pandemic levels.
  • The study highlights the importance of strengthening organized cancer screening programs to prevent disease progression and improve health outcomes for women.
  • Amaxsell Thiago Barros de Souza, lead author of the study, emphasized the need for sustained investment in women's health to address the structural vulnerabilities exposed by the pandemic.

Statistics:

  • 30% reduction in Pap smear testing nationwide during the pandemic period compared to the pre-pandemic period (p < 0.001).
  • 40% decrease in Pap smear testing in rural areas compared to 25% in urban areas.
  • 25,000 fewer Pap smear tests performed in 2020-2021 compared to 2018-2019 nationwide.
  • 12.5% increase in cytopathological exams performed in 2022-2023 compared to 2020-2021.

Sources:

  • Impact of the COVID-19 Pandemic on Cervical Cancer Screening in Brazil: A Nationwide Population-Based Study. COVID, 2025,5(9):151.
  • Federal University of Rio Grande do Norte, Natal, Brazil.
  • Savio Ferreira Camargo, Janaina Cristiana de Oliveira Crispim, Additional authors.

Read more